Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Foglierini

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Nature|August 29, 2017
Public antibodies to malaria antigens generated by two LAIR1 insertion modalitiesKathrin Pieper, Joshua Tan, Luca Piccoli, et al.
Science Advances|April 24, 2026
Targeting PD-1<sup>+</sup> T cells with chimeric antigen receptors to reduce the HIV reservoirLaura Ermellino, Riddhima Banga, Spiros Georgakis, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Cell Reports|September 3, 2020
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent ElicitationCrystal Sao-Fong Cheung, Alexander Fruehwirth, Philipp Carl Georg Paparoditis, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Nature|August 29, 2017
Public antibodies to malaria antigens generated by two LAIR1 insertion modalitiesKathrin Pieper, Joshua Tan, Luca Piccoli, et al.
Science Advances|April 24, 2026
Targeting PD-1<sup>+</sup> T cells with chimeric antigen receptors to reduce the HIV reservoirLaura Ermellino, Riddhima Banga, Spiros Georgakis, et al.
Science (New York, N.Y.)|July 16, 2016
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionKarin Stettler, Martina Beltramello, Diego A Espinosa, et al.
Cell Reports|September 3, 2020
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent ElicitationCrystal Sao-Fong Cheung, Alexander Fruehwirth, Philipp Carl Georg Paparoditis, et al.
Pageof 5